{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T01:52:47Z","timestamp":1781574767887,"version":"3.54.5"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:00:00Z","timestamp":1781568000000},"content-version":"vor","delay-in-days":48,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100018764","name":"Semnan University of Medical Sciences and Health Services","doi-asserted-by":"publisher","award":["2188"],"award-info":[{"award-number":["2188"]}],"id":[{"id":"10.13039\/501100018764","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007432","name":"Shiraz Institute for Cancer Research, Shiraz University of Medical Sciences","doi-asserted-by":"publisher","award":["ICR-100-508"],"award-info":[{"award-number":["ICR-100-508"]}],"id":[{"id":"10.13039\/501100007432","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-026-05116-8","type":"journal-article","created":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T09:10:18Z","timestamp":1777453818000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Adipose-derived mesenchymal stromal cells promote an exhaustion-associated phenotype in T cells through TIM-3 upregulation independent of PD-1"],"prefix":"10.1007","volume":"17","author":[{"given":"Shohreh","family":"Mirshafiei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faezeh","family":"Absalan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bahman","family":"Yousefi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud","family":"Shariat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdol-Rasoul","family":"Talei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasoul","family":"Baharlou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fereshteh","family":"Mehdipour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abbas","family":"Ghaderi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,29]]},"reference":[{"issue":"6","key":"5116_CR1","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.1111\/cas.15751","volume":"114","author":"Y Komohara","year":"2023","unstructured":"Komohara Y, et al. Involvement of protumor macrophages in breast cancer progression and characterization of macrophage phenotypes. Cancer Sci. 2023;114(6):2220.","journal-title":"Cancer Sci"},{"issue":"1","key":"5116_CR2","doi-asserted-by":"publisher","first-page":"p188587","DOI":"10.1016\/j.bbcan.2021.188587","volume":"1876","author":"C Nascimento","year":"2021","unstructured":"Nascimento C, Ferreira F. Tumor microenvironment of human breast cancer, and feline mammary carcinoma as a potential study model. Biochim Et Biophys Acta (BBA)-Reviews Cancer. 2021;1876(1):p188587.","journal-title":"Biochim Et Biophys Acta (BBA)-Reviews Cancer"},{"issue":"2","key":"5116_CR3","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/s41573-018-0004-1","volume":"18","author":"X Chen","year":"2019","unstructured":"Chen X, Song E. Turning foes to friends: targeting cancer-associated fibroblasts. Nat Rev Drug Discov. 2019;18(2):99\u2013115.","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"5116_CR4","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1080\/1354750X.2024.2309541","volume":"29","author":"T Abbasi-Dokht","year":"2024","unstructured":"Abbasi-Dokht T, et al. Assessing angiogenesis factors as prognostic biomarkers in breast cancer patients and their association with clinicopathological factors. Biomarkers. 2024;29(1):36\u201343.","journal-title":"Biomarkers"},{"issue":"2","key":"5116_CR5","doi-asserted-by":"publisher","first-page":"129","DOI":"10.20892\/j.issn.2095-3941.2016.0033","volume":"14","author":"AHN Kamdje","year":"2017","unstructured":"Kamdje AHN, et al. Mesenchymal stromal cells\u2019 role in tumor microenvironment: involvement of signaling pathways. Cancer biology Med. 2017;14(2):129.","journal-title":"Cancer biology Med"},{"key":"5116_CR6","doi-asserted-by":"publisher","first-page":"096368972312200","DOI":"10.1177\/09636897231220073","volume":"32","author":"L Zhang","year":"2023","unstructured":"Zhang L. The role of mesenchymal stem cells in modulating the breast Cancer Microenvironment. Cell Transplant. 2023;32:09636897231220073.","journal-title":"Cell Transplant"},{"issue":"12","key":"5116_CR7","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1016\/j.ejca.2011.11.003","volume":"48","author":"Z-G Zhao","year":"2012","unstructured":"Zhao Z-G, et al. The characteristics and immunoregulatory functions of regulatory dendritic cells induced by mesenchymal stem cells derived from bone marrow of patient with chronic myeloid leukaemia. Eur J Cancer. 2012;48(12):1884\u201395.","journal-title":"Eur J Cancer"},{"issue":"12","key":"5116_CR8","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/j.imbio.2018.08.002","volume":"223","author":"F Salami","year":"2018","unstructured":"Salami F, et al. Immunomodulatory effects of mesenchymal stem cells on leukocytes with emphasis on neutrophils. Immunobiology. 2018;223(12):786\u201391.","journal-title":"Immunobiology"},{"issue":"1","key":"5116_CR9","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1186\/s13287-019-1447-y","volume":"10","author":"F Liu","year":"2019","unstructured":"Liu F, et al. MSC-secreted TGF-\u03b2 regulates lipopolysaccharide-stimulated macrophage M2-like polarization via the Akt\/FoxO1 pathway. Stem Cell Res Ther. 2019;10(1):345.","journal-title":"Stem Cell Res Ther"},{"issue":"2","key":"5116_CR10","first-page":"236","volume":"22","author":"M Fakhimi","year":"2019","unstructured":"Fakhimi M, et al. Helios, CD73 and CD39 induction in regulatory T cells exposed to adipose derived mesenchymal stem cells. Cell J (Yakhteh). 2019;22(2):236.","journal-title":"Cell J (Yakhteh)"},{"issue":"1","key":"5116_CR11","first-page":"137","volume":"19","author":"B Bahrami","year":"2016","unstructured":"Bahrami B, et al. Adipose derived stem cells exert immunomodulatory effects on natural killer cells in breast cancer. Cell J (Yakhteh). 2016;19(1):137.","journal-title":"Cell J (Yakhteh)"},{"issue":"12","key":"5116_CR12","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1002\/cbin.11062","volume":"42","author":"F Mehdipour","year":"2018","unstructured":"Mehdipour F, et al. Mesenchymal stem cells induced anti-inflammatory features in B cells from breast tumor draining lymph nodes. Cell Biol Int. 2018;42(12):1658\u201369.","journal-title":"Cell Biol Int"},{"issue":"5","key":"5116_CR13","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.3390\/ijms19051389","volume":"19","author":"T Shi","year":"2018","unstructured":"Shi T, et al. Cancer immunotherapy: a focus on the regulation of immune checkpoints. Int J Mol Sci. 2018;19(5):1389.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"5116_CR14","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1038\/s41590-019-0312-6","volume":"20","author":"BC Miller","year":"2019","unstructured":"Miller BC, et al. Subsets of exhausted CD8\u2009+\u2009T cells differentially mediate tumor control and respond to checkpoint blockade. Nat Immunol. 2019;20(3):326\u201336.","journal-title":"Nat Immunol"},{"issue":"5","key":"5116_CR15","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/j.immuni.2020.04.014","volume":"52","author":"J-C Beltra","year":"2020","unstructured":"Beltra J-C, et al. Developmental relationships of four exhausted CD8\u2009+\u2009T cell subsets reveals underlying transcriptional and epigenetic landscape control mechanisms. Immunity. 2020;52(5):825\u201341. e8.","journal-title":"Immunity"},{"issue":"3","key":"5116_CR16","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/s41577-019-0224-6","volume":"20","author":"Y Wolf","year":"2020","unstructured":"Wolf Y, Anderson AC, Kuchroo VK. TIM3 comes of age as an inhibitory receptor. Nat Rev Immunol. 2020;20(3):173\u201385.","journal-title":"Nat Rev Immunol"},{"issue":"12","key":"5116_CR17","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1158\/2326-6066.CIR-22-0939","volume":"11","author":"JJ Roetman","year":"2023","unstructured":"Roetman JJ, et al. Tumor-Reactive CD8\u2009+\u2009T Cells Enter a TCF1\u2009+\u2009PD-1\u2009\u2013\u2009Dysfunctional State. Cancer Immunol Res. 2023;11(12):1630\u201341.","journal-title":"Cancer Immunol Res"},{"issue":"1","key":"5116_CR18","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.immuni.2022.12.002","volume":"56","author":"N Prokhnevska","year":"2023","unstructured":"Prokhnevska N, et al. CD8\u2009+\u2009T cell activation in cancer comprises an initial activation phase in lymph nodes followed by effector differentiation within the tumor. Immunity. 2023;56(1):107\u201324. e5.","journal-title":"Immunity"},{"issue":"2","key":"5116_CR19","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/s41577-019-0223-7","volume":"20","author":"A Kallies","year":"2020","unstructured":"Kallies A, Zehn D, Utzschneider DT. Precursor exhausted T cells: key to successful immunotherapy? Nat Rev Immunol. 2020;20(2):128\u201336.","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"5116_CR20","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/s41577-021-00574-3","volume":"22","author":"M Philip","year":"2022","unstructured":"Philip M, Schietinger A. CD8\u2009+\u2009T cell differentiation and dysfunction in cancer. Nat Rev Immunol. 2022;22(4):209\u201323.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"5116_CR21","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.immuni.2018.12.021","volume":"50","author":"I Siddiqui","year":"2019","unstructured":"Siddiqui I, et al. Intratumoral Tcf1\u2009+\u2009PD-1\u2009+\u2009CD8+ T cells with stem-like properties promote tumor control in response to vaccination and checkpoint blockade immunotherapy. Immunity. 2019;50(1):195\u2013211. e10.","journal-title":"Immunity"},{"issue":"8","key":"5116_CR22","first-page":"9452","volume":"8","author":"G Cheng","year":"2015","unstructured":"Cheng G, et al. Expression of Tim-3 in gastric cancer tissue and its relationship with prognosis. Int J Clin Exp Pathol. 2015;8(8):9452.","journal-title":"Int J Clin Exp Pathol"},{"key":"5116_CR23","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.lungcan.2018.04.009","volume":"121","author":"H Su","year":"2018","unstructured":"Su H, et al. Characterization of TIM-3 expression and its prognostic value in patients with surgically resected lung adenocarcinoma. Lung Cancer. 2018;121:18\u201324.","journal-title":"Lung Cancer"},{"issue":"6","key":"5116_CR24","first-page":"808","volume":"31","author":"P Ji","year":"2015","unstructured":"Ji P, et al. Up-regulation of TIM-3 on CD4\u2009+\u2009tumor infiltrating lymphocytes predicts poor prognosis in human non-small-cell lung cancer. Xi bao yu fen zi Mian yi xue za zhi=. Chin J Cell Mol Immunol. 2015;31(6):808\u201311.","journal-title":"Chin J Cell Mol Immunol"},{"issue":"11","key":"5116_CR25","doi-asserted-by":"publisher","first-page":"e1502128","DOI":"10.1080\/2162402X.2018.1502128","volume":"7","author":"S Burugu","year":"2018","unstructured":"Burugu S, et al. TIM-3 expression in breast cancer. Oncoimmunology. 2018;7(11):e1502128.","journal-title":"Oncoimmunology"},{"issue":"4","key":"5116_CR26","doi-asserted-by":"publisher","first-page":"406","DOI":"10.4048\/jbc.2018.21.e61","volume":"21","author":"KD Byun","year":"2018","unstructured":"Byun KD, et al. T-cell immunoglobulin mucin 3 expression on tumor infiltrating lymphocytes as a positive prognosticator in triple-negative breast cancer. J breast cancer. 2018;21(4):406\u201314.","journal-title":"J breast cancer"},{"issue":"4","key":"5116_CR27","doi-asserted-by":"publisher","first-page":"557","DOI":"10.3892\/mco.2017.1360","volume":"7","author":"H Zhang","year":"2017","unstructured":"Zhang H, et al. T-cell immunoglobulin mucin\u20133 expression in invasive ductal breast carcinoma: Clinicopathological correlations and association with tumor infiltration by cytotoxic lymphocytes. Mol Clin Oncol. 2017;7(4):557\u201363.","journal-title":"Mol Clin Oncol"},{"issue":"1","key":"5116_CR28","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1186\/s12885-021-08054-6","volume":"21","author":"N Cabioglu","year":"2021","unstructured":"Cabioglu N, et al. TIM3 expression on TILs is associated with poor response to neoadjuvant chemotherapy in patients with locally advanced triple-negative breast cancer. BMC Cancer. 2021;21(1):357.","journal-title":"BMC Cancer"},{"issue":"5","key":"5116_CR29","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.4149\/neo_2021_210127N141","volume":"68","author":"A Abbasov","year":"2021","unstructured":"Abbasov A, et al. Differential expression of Novel Immune Checkpoint receptors on Tumor infiltrating lymphocytes in patients with locally advanced breast Cancer after Neoadjuvant Chemotherapy. Neoplasma. 2021;68(5):1079\u201390.","journal-title":"Neoplasma"},{"key":"5116_CR30","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.molimm.2020.10.002","volume":"128","author":"S Shariati","year":"2020","unstructured":"Shariati S, et al. Significance of TIM-3 expression by CD4\u2009+\u2009and CD8\u2009+\u2009T lymphocytes in tumor-draining lymph nodes from patients with breast cancer. Mol Immunol. 2020;128:47\u201354.","journal-title":"Mol Immunol"},{"issue":"4","key":"5116_CR31","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1080\/14653240600855905","volume":"8","author":"M Dominici","year":"2006","unstructured":"Dominici M, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8(4):315\u20137.","journal-title":"Cytotherapy"},{"issue":"1","key":"5116_CR32","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s13287-021-02179-y","volume":"12","author":"S Chakraborty","year":"2021","unstructured":"Chakraborty S, et al. CD10 marks non-canonical PPAR\u03b3-independent adipocyte maturation and browning potential of adipose-derived stem cells. Stem Cell Res Ther. 2021;12(1):109.","journal-title":"Stem Cell Res Ther"},{"issue":"7","key":"5116_CR33","doi-asserted-by":"publisher","first-page":"918","DOI":"10.3390\/biom11070918","volume":"11","author":"WK Ong","year":"2021","unstructured":"Ong WK, Chakraborty S, Sugii S. Adipose tissue: understanding the heterogeneity of stem cells for regenerative medicine. Biomolecules. 2021;11(7):918.","journal-title":"Biomolecules"},{"issue":"1","key":"5116_CR34","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1186\/s13287-022-02985-y","volume":"13","author":"J Liu","year":"2022","unstructured":"Liu J, et al. Mesenchymal stem cells and their microenvironment. Stem Cell Res Ther. 2022;13(1):429.","journal-title":"Stem Cell Res Ther"},{"issue":"3","key":"5116_CR35","doi-asserted-by":"publisher","first-page":"256","DOI":"10.4252\/wjsc.v6.i3.256","volume":"6","author":"PC Baer","year":"2014","unstructured":"Baer PC. Adipose-derived mesenchymal stromal\/stem cells: an update on their phenotype in vivo and in vitro. World J Stem Cells. 2014;6(3):256.","journal-title":"World J Stem Cells"},{"issue":"2","key":"5116_CR36","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.stemcr.2014.01.002","volume":"2","author":"WK Ong","year":"2014","unstructured":"Ong WK, et al. Identification of specific cell-surface markers of adipose-derived stem cells from subcutaneous and visceral fat depots. Stem cell Rep. 2014;2(2):171\u20139.","journal-title":"Stem cell Rep"},{"issue":"2","key":"5116_CR37","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s00262-021-02998-1","volume":"71","author":"MA Kursunel","year":"2022","unstructured":"Kursunel MA, et al. Small cell lung cancer stem cells display mesenchymal properties and exploit immune checkpoint pathways in activated cytotoxic T lymphocytes. Cancer Immunol Immunother. 2022;71(2):445\u201359.","journal-title":"Cancer Immunol Immunother"},{"issue":"3","key":"5116_CR38","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1002\/cbin.10905","volume":"42","author":"M Razmkhah","year":"2018","unstructured":"Razmkhah M, et al. Cancer and normal adipose-derived mesenchymal stem cells (ASCs): do they have differential effects on tumor and immune cells? Cell Biol Int. 2018;42(3):334\u201343.","journal-title":"Cell Biol Int"},{"issue":"24","key":"5116_CR39","doi-asserted-by":"publisher","first-page":"22196","DOI":"10.1002\/cam4.6802","volume":"12","author":"I Yilmaz","year":"2023","unstructured":"Yilmaz I, et al. Immune checkpoint status and exhaustion-related phenotypes of CD8\u2009+\u2009T cells from the tumor\u2010draining regional lymph nodes in breast cancer. Cancer Med. 2023;12(24):22196\u2013205.","journal-title":"Cancer Med"},{"issue":"9","key":"5116_CR40","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/j.imbio.2016.04.005","volume":"221","author":"S Zhu","year":"2016","unstructured":"Zhu S, et al. Tim-3 identifies exhausted follicular helper T cells in breast cancer patients. Immunobiology. 2016;221(9):986\u201393.","journal-title":"Immunobiology"},{"issue":"2","key":"5116_CR41","doi-asserted-by":"publisher","first-page":"e000422","DOI":"10.1136\/jitc-2019-000422","volume":"8","author":"Y Shen","year":"2020","unstructured":"Shen Y, et al. PD-1 does not mark tumor-infiltrating CD8\u2009+\u2009T cell dysfunction in human gastric cancer. J Immunother Cancer. 2020;8(2):e000422.","journal-title":"J Immunother Cancer"},{"issue":"1","key":"5116_CR42","doi-asserted-by":"publisher","first-page":"4297","DOI":"10.1038\/s41467-018-06653-9","volume":"9","author":"CA Egelston","year":"2018","unstructured":"Egelston CA, et al. Human breast tumor-infiltrating CD8\u2009+\u2009T cells retain polyfunctionality despite PD-1 expression. Nat Commun. 2018;9(1):4297.","journal-title":"Nat Commun"},{"issue":"10","key":"5116_CR43","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1084\/jem.20100643","volume":"207","author":"K Sakuishi","year":"2010","unstructured":"Sakuishi K, et al. Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity. J Exp Med. 2010;207(10):2187\u201394.","journal-title":"J Exp Med"},{"issue":"17","key":"5116_CR44","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1089\/scd.2018.0033","volume":"27","author":"K Zhou","year":"2018","unstructured":"Zhou K, et al. Immunosuppression of human adipose-derived stem cells on T cell subsets via the reduction of NF-kappaB activation mediated by PD-L1\/PD-1 and Gal-9\/TIM-3 pathways. Stem Cells Dev. 2018;27(17):1191\u2013202.","journal-title":"Stem Cells Dev"},{"issue":"1","key":"5116_CR45","doi-asserted-by":"publisher","first-page":"14284","DOI":"10.1038\/srep14284","volume":"5","author":"Z Xishan","year":"2015","unstructured":"Xishan Z, et al. Jagged-2 enhances immunomodulatory activity in adipose derived mesenchymal stem cells. Sci Rep. 2015;5(1):14284.","journal-title":"Sci Rep"},{"issue":"1","key":"5116_CR46","first-page":"6516854","volume":"2017","author":"Y Rubtsov","year":"2017","unstructured":"Rubtsov Y, et al. Molecular mechanisms of immunomodulation properties of mesenchymal stromal cells: a new insight into the role of ICAM-1. Stem cells Int. 2017;2017(1):6516854.","journal-title":"Stem cells Int"},{"issue":"1","key":"5116_CR47","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s00441-023-03801-6","volume":"394","author":"M Mahmoud","year":"2023","unstructured":"Mahmoud M, Abdel-Rasheed M. Influence of type 2 diabetes and obesity on adipose mesenchymal stem\/stromal cell immunoregulation. Cell Tissue Res. 2023;394(1):33\u201353.","journal-title":"Cell Tissue Res"},{"issue":"1","key":"5116_CR48","doi-asserted-by":"publisher","first-page":"348","DOI":"10.3390\/ijms22010348","volume":"22","author":"A-M Vacaru","year":"2020","unstructured":"Vacaru A-M, et al. Enhanced suppression of immune cells in vitro by MSC overexpressing FasL. Int J Mol Sci. 2020;22(1):348.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"5116_CR49","doi-asserted-by":"publisher","first-page":"237","DOI":"10.3233\/CBM-210114","volume":"32","author":"Y Cao","year":"2021","unstructured":"Cao Y, et al. Role of Tim-3 in regulating tumorigenesis, inflammation, and antitumor immunity therapy. Cancer Biomarkers. 2021;32(2):237\u201348.","journal-title":"Cancer Biomarkers"},{"key":"5116_CR50","doi-asserted-by":"publisher","first-page":"102614","DOI":"10.1016\/j.ctrv.2023.102614","volume":"120","author":"M Borgeaud","year":"2023","unstructured":"Borgeaud M, et al. Novel targets for immune-checkpoint inhibition in cancer. Cancer Treat Rev. 2023;120:102614.","journal-title":"Cancer Treat Rev"},{"issue":"11","key":"5116_CR51","doi-asserted-by":"publisher","first-page":"3405","DOI":"10.1007\/s00262-023-03516-1","volume":"72","author":"N Sauer","year":"2023","unstructured":"Sauer N, et al. TIM-3 as a promising target for cancer immunotherapy in a wide range of tumors. Cancer Immunol Immunother. 2023;72(11):3405\u201325.","journal-title":"Cancer Immunol Immunother"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-026-05116-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-05116-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-05116-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T01:03:05Z","timestamp":1781571785000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-026-05116-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,29]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5116"],"URL":"https:\/\/doi.org\/10.1007\/s12672-026-05116-8","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,29]]},"assertion":[{"value":"29 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study complied with the guidelines for human studies and was conducted in accordance with the World Medical Association Declaration of Helsinki. The study protocol was approved by the Ethical Board of the Semnan University of Medical Sciences (IR.SEMUMS.REC.1402.172).\u00a0Informed consent to participate was obtained in writing from all individuals included in the study. All participants were informed about the study procedures and provided explicit permission for the use of their samples and data for research purposes. Any required institutional permissions or approvals were also obtained.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and\u00a0consent to participate"}},{"value":"Not applicable, as data of the study was anonymous.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"900"}}